Correlation analysis with clinicopathological parameters showed that high levels of DUXAP8 correlated with the TNM stage of cancer, tumor size, microvascular invasion, and distant metastasis (Figure 1E; Supplementary Table S2), and that HCC patients with high DUXAP8 expression tended to have a poorer prognosis (Figure 1F). This evidence concerns the gene DUXAP8 and cancer.